Skip to main content
SpringerLink
Log in

Der Proteasomeninhibitor Bortezomib

Eine neue Option bei therapieresistenter akuter Nierentransplantatrejektion?

The proteasome inhibitor bortezomib

A new option for therapy-resistant acute rejection of kidney transplantation?

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Mattingly LH, Gault RA, Murphy WJ (2007) Use of systemic proteasome inhibition as an immune-modulating agent in disease. Endocr Metab Immune Disord Drug Targets 7:29–34

    PubMed  CAS  Google Scholar 

  2. Perry DK, Burns JM, Pollinger HS et al (2009) Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant 9:201–209

    Article  PubMed  CAS  Google Scholar 

  3. Teicher BA, Ara G, Herbst R et al (1999) The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res 5:2638–2645

    PubMed  CAS  Google Scholar 

  4. The U.S. Organ procurement and transplantation network and the scientific registry of transplant recipients: Annual report 2007. www.ustransplant.org

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Kinderklinik und Kinderpoliklinik, Dr. von Haunersches Kinderspital, LMU München, Lindwurmstr. 4, 80337, München, Deutschland

    M.R. Benz

  2. Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg, Heidelberg, Deutschland

    B. Tönshoff

Authors
  1. M.R. Benz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Tönshoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M.R. Benz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benz, M., Tönshoff, B. Der Proteasomeninhibitor Bortezomib. Nephrologe 4, 154–155 (2009). https://doi.org/10.1007/s11560-009-0296-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-009-0296-6

Search

Navigation